Lung Myofibroblast De-Differentiation and Fibrosis Resolution Depend on cAMP-mediated Inhibition of HuR.
肺肌成纤维细胞去分化和纤维化消退取决于 cAMP 介导的 HuR 抑制。
基本信息
- 批准号:10661944
- 负责人:
- 金额:$ 16.96万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-04-15 至 2028-02-29
- 项目状态:未结题
- 来源:
- 关键词:Adenylate CyclaseAffectAnimal ModelAntigensApoptosisApoptoticArchitectureAreaAwardBioinformaticsBiologyBleomycinCRISPR/Cas technologyCell Differentiation processCell LineChemosensitizationCicatrixClinicalClinical DataCollagenCritical CareCyclic AMPDataDevelopmentDevelopment PlansEducational workshopEffector CellEnvironmentExhibitsFellowshipFibroblastsFibrosisFluorescence MicroscopyForskolinFunctional disorderG-Protein-Coupled ReceptorsGTP-Binding Protein alpha Subunits, GsGasesGene ExpressionGene Expression ProfileGenerationsGenesGrantHumanImageImmunofluorescence MicroscopyImpairmentIn VitroIndividualInstitutionInternal MedicineInvestigationKnock-outKnockout MiceKnowledgeLigationLungLung diseasesMediatingMedicineMentorsMessenger RNAModelingMolecularMolecular BiologyMusMyofibroblastPatientsPhenotypePhosphodiesterase InhibitorsPhosphorylationPhysiciansPost-Transcriptional RegulationProcessProliferatingProteinsPulmonary FibrosisRNARNA-Binding ProteinsReagentRegulationResearchResearch DesignResearch PersonnelResistanceResolutionRoleScientistSecond Messenger SystemsSignal PathwaySignal TransductionSystemTechniquesTestingTherapeuticTherapeutic EffectTimeTissuesTrainingTranscriptTransgenic AnimalsTransgenic MiceTranslatingTranslationsUntranslated RNAWild Type MouseWritingcareercareer developmentcell dedifferentiationclinical trainingexperiencefibrotic lungfibrotic lung diseaseidiopathic pulmonary fibrosisin vivoin vivo Modelinhibitorlung injurymRNA Stabilitymeetingsmouse modelmultidisciplinarynovelpharmacologicposttranscriptionalresearch and developmentresponsible research conductrestorationskillstraffickingtranscriptome sequencingtranscriptomicstranslational impacttranslational scientistwound healing
项目摘要
Project Summary/Abstract:
This proposal describes a five-year research and career development plan intended to support the applicant’s
progression to an independent physician-scientist investigating mechanisms of lung myofibroblast (MF) de-
differentiation/clearance and pulmonary fibrosis resolution.
Research Plan: Idiopathic pulmonary fibrosis (IPF) is the deadliest fibrotic lung disease, affecting millions of
individuals worldwide, with limited treatment options that fail to reverse established fibrosis. MFs are the
ultimate effector cells of IPF whose persistence following wound repair – a consequence of their apoptosis
resistance – leads to progressive lung scarring and stiffness, distorting tissue architecture and impairing gas
exchange. Clearance of lung MFs – through their phenotypic de-differentiation and restoration of apoptosis
sensitivity – has the potential to resolve fibrosis. The applicant has discovered that lung MF de-differentiation
can proceed via distinct transitional phenotypes and that post-transcriptional regulation of mRNAs is crucial to
this process. In this proposal, he will investigate the role of the endogenous anti-fibrotic brake cyclic adenosine
monophosphate (cAMP) and its regulation of the master post-transcriptional regulator human antigen R (HuR)
in MF de-differentiation and fibrosis resolution.
Applicant and Training Plan: The applicant holds an MD degree and has completed clinical training in Internal
Medicine, Pulmonary, and Critical Care Medicine. During his fellowship and prior research endeavors, he has
gained experience with in vitro systems and basic lab techniques in fibroblast biology. As part of his career
development, the applicant will participate in mentored research designed to develop new knowledge and
proficiency in RNA biology, CRISPR/Cas9 techniques, immunofluorescence microscopy, bioinformatics, and
use of novel transgenic mice for in vivo modeling and investigation of pulmonary fibrosis. Acquiring these new
skills and experiences will greatly facilitate his development into an independent investigator studying the
mechanisms by which MFs can be de-differentiated and cleared, enabling strategies to promote fibrosis
resolution. Training in these areas will be acquired under the guidance of his experienced mentoring team, and
through participation in seminars, lab meetings, coursework, workshops, and national meetings. He will also
receive training in grant writing and responsible conduct of research. The outstanding institutional research
environment provides the applicant abundant opportunities for interaction with investigators in RNA and
molecular biology, pulmonary and extra-pulmonary fibrosis, as well as with basic and translational scientists.
Available facilities for advanced imaging, RNA sequencing, and transgenic animal modeling will be utilized.
This application will thus enable a well-trained and committed junior investigator to develop an independent
career in the investigation of cellular and molecular mechanisms that can be translated into the resolution of
established pulmonary fibrosis – the holy grail of research in this field and an enormous unmet clinical need.
项目摘要/摘要:
该建议描述了一项为期五年的研究和职业发展计划,旨在支持申请人的
发展为独立的物理科学家调查肺肌纤维细胞(MF)的机制
分化/清除和肺纤维化分辨率。
研究计划:特发性肺纤维化(IPF)是最致命的纤维化肺部疾病,影响了数百万
在全球范围内的个人,有限的治疗选择未能逆转纤维化。 MF是
IPF的最终效应细胞,其持久性伤口修复后的持久性 - 凋亡的结果
抗性 - 导致进行性肺部疤痕和僵硬,扭曲组织结构和损害气体
交换。肺MF的清除 - 通过表型去差异和凋亡的恢复
灵敏度 - 有可能解决纤维化。申请人发现肺MF脱不同
可以通过不同的过渡表型进行,并且mRNA的转录后调节对
这个过程。在此提案中,他将研究内源性抗纤维化制动循环腺苷的作用
单磷酸盐(CAMP)及其对主要后调节剂人体抗原R(HUR)的调节
在MF脱不同和纤维化分辨率中。
申请人和培训计划:申请人拥有MD学位,并完成了内部临床培训
医学,肺部和重症监护医学。在他的奖学金和事先研究期间,他有
在体外系统和成纤维细胞生物学的基本实验室技术方面获得了经验。作为他职业生涯的一部分
开发,适用的将参加旨在发展新知识的修订研究和
熟练RNA生物学,CRISPR/CAS9技术,免疫荧光显微镜,生物信息学和
使用新型转基因小鼠进行体内建模和肺纤维化研究。获取这些新
技能和经验将极大地支持他的发展,以研究
可以将MF脱离分化和清除的机制,从而促进策略促进纤维化
解决。这些领域的培训将在他的经验精神团队的指导下获得
通过参加SEMIAR,实验室会议,课程,讲习班和国家会议。他也会
接受赠款写作和负责任的研究培训。杰出的机构研究
环境为申请人提供了与RNA调查人员互动的丰富机会,
分子生物学,肺部和肺外纤维化以及基本和翻译的科学家。
将利用用于高级成像,RNA测序和转基因动物建模的可用设施。
因此,该应用程序将使训练有素且致力于的初级调查员能够开发独立
研究细胞和分子机制的职业,可以将其转化为分辨率
建立的肺纤维化 - 该领域的研究的圣杯和巨大的未满足临床需求。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sean Michael Fortier其他文献
Sean Michael Fortier的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
肾—骨应答调控骨骼VDR/RXR对糖尿病肾病动物模型FGF23分泌的影响及中药的干预作用
- 批准号:82074395
- 批准年份:2020
- 资助金额:55 万元
- 项目类别:面上项目
基于细胞自噬调控的苦参碱对多囊肾小鼠动物模型肾囊肿形成的影响和机制研究
- 批准号:
- 批准年份:2019
- 资助金额:33 万元
- 项目类别:地区科学基金项目
NRSF表达水平对抑郁模型小鼠行为的影响及其分子机制研究
- 批准号:81801333
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
靶向诱导merlin/p53协同性亚细胞穿梭对听神经瘤在体生长的影响
- 批准号:81800898
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
伪狂犬病病毒激活三叉神经节细胞对其NF-кB和PI3K/Akt信号转导通路影响的分子机制研究
- 批准号:31860716
- 批准年份:2018
- 资助金额:39.0 万元
- 项目类别:地区科学基金项目
相似海外基金
The effect of biased agonism at the Mu-Opioid receptor on drug seeking behavior
Mu-阿片受体的偏向激动对药物寻求行为的影响
- 批准号:
10590603 - 财政年份:2022
- 资助金额:
$ 16.96万 - 项目类别:
Repurposing of Maraviroc for the treatment of neuropathic pain
重新利用马拉韦罗治疗神经性疼痛
- 批准号:
10586296 - 财政年份:2022
- 资助金额:
$ 16.96万 - 项目类别:
Priming the proteasome to protect against aging and Alzheimer's disease
启动蛋白酶体以预防衰老和阿尔茨海默病
- 批准号:
10448146 - 财政年份:2022
- 资助金额:
$ 16.96万 - 项目类别: